Verano Holdings (VRNO) Accumulated Expenses (2021 - 2026)
Verano Holdings' (VRNO) quarterly Accumulated Expenses came in at $55.5 million in Q1 2026, down 5.08% year-on-year from $58.5 million in Q1 2025, and down 19.93% on a QoQ basis from $69.3 million in Q4 2025.
Verano Holdings (VRNO) Accumulated Expenses (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Accumulated Expenses data on file, last reported at $55.5 million in Q1 2026.
- On a quarterly basis, Accumulated Expenses fell 5.08% year-over-year to $55.5 million in Q1 2026; TTM through Mar 2026 was $55.5 million, a 5.08% decrease from a year earlier, with the FY2025 full-year figure at $69.3 million, up 0.52% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $55.5 million, down from $69.3 million in the prior quarter.
- Over the last five years, Accumulated Expenses for VRNO reached as high as $71.8 million in Q3 2025 and fell as low as $30.8 million in Q2 2022.
- Historically, Accumulated Expenses has averaged $56.1 million across 5 years, with a median of $59.9 million in 2024.
- Across the five-year window, Accumulated Expenses jumped 74.43% in 2023 and retreated 6.49% in 2025, its largest moves.
- Year by year, Accumulated Expenses stood at $41.8 million in 2022, then jumped by 59.87% to $66.8 million in 2023, then advanced by 3.26% to $68.9 million in 2024, then gained by 0.52% to $69.3 million in 2025, then retreated by 19.93% to $55.5 million in 2026.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $55.5 million in Q1 2026, $69.3 million in Q4 2025, and $71.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.49 Mn |
| Dec 31, 2025 | 69.30 Mn |
| Sep 30, 2025 | 71.76 Mn |
| Jun 30, 2025 | 61.51 Mn |
| Mar 31, 2025 | 58.46 Mn |
| Dec 31, 2024 | 68.94 Mn |
| Sep 30, 2024 | 69.92 Mn |
| Jun 30, 2024 | 65.78 Mn |
| Mar 31, 2024 | 61.30 Mn |
| Dec 31, 2023 | 66.77 Mn |
| Sep 30, 2023 | 52.11 Mn |
| Jun 30, 2023 | 53.68 Mn |
| Mar 31, 2023 | 37.91 Mn |
| Dec 31, 2022 | 41.76 Mn |
| Sep 30, 2022 | 32.05 Mn |
| Jun 30, 2022 | 30.77 Mn |
| Dec 31, 2021 | 42.15 Mn |